US Patent 9,523,093
United States Patent and Trademark Office
University of Iowa Research Foundation (Iowa City, IA, US)
The present invention is directed to RNA interference (RNAi) molecules targeted against a Huntington's disease nucleic acid sequence, and methods of using these RNAi molecules to treat Huntington's disease.
Davidson, Beverly L. and Mas Monteys, Alejandro Huntington's disease therapeutic compounds. US Patent 9,523,093 filed May 20, 2015 and issued December 20, 2016. https://ir.uiowa.edu/patents/677